PATENT CLAIM ANALYSIS

Application Number: 15979105
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-05
Patent Classification: ["514", "259300"]

Abstract:
Pharmaceutical compositions comprising a molecular inhibitor of Npr1 are disclosed. Also disclosed are methods of treating, reducing, or preventing acute and/or chronic pruritus in a mammal comprising administering a pharmaceutical composition comprising a molecular inhibitor of Npr1.

Claim (Index 16):
The method of  claim 5 , wherein the mammal is a dog.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 93.0
- Lexical Diversity: 1.51852
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14774597', '14443602', '15105224', '15463051', '14380078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7003772412643899
- 35 USC 102 Novelty (BERT): 0.530172319553837
- Combined Prediction Score: 0.6833567490933347
- Mean Citation Score: 208.8756
- Max Citation Score: 234.87299
- Similarity Product: 116.1516539489147

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test